---
figid: PMC11853781__cimb-47-00126-g004
figtitle: Multi-pathway mechanisms of luteolin in inhibiting colorectal cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11853781
filename: cimb-47-00126-g004.jpg
figlink: /pmc/articles/PMC11853781/figure/F4/
number: F4
caption: 'The multi-pathway mechanisms of luteolin in inhibiting colorectal cancer.
  (The anti-cancer effects of luteolin are achieved through three major pathways:
  (1) Inhibition of cell proliferation and induction of apoptosis—downregulating Cyclin
  D1/CDK4, activating Caspase-3/9, and modulating the PI3K/Akt pathway; (2) suppression
  of cell migration and invasion—inhibiting MMPs, regulating EMT-related proteins
  (E-cadherin, N-cadherin, Vimentin), and interfering with the Wnt/β-catenin pathway;
  (3) antioxidant and anti-inflammatory effects—reducing ROS levels, enhancing antioxidant
  enzyme activities (SOD, CAT), and modulating the NF-κB signaling pathway to create
  an environment unfavorable for tumor progression)'
papertitle: 'Luteolin in Inflammatory Bowel Disease and Colorectal Cancer: A Disease
  Continuum Perspective'
reftext: Fang Liu, et al. Curr Issues Mol Biol. 2025 Feb;47(2).
year: '2025'
doi: 10.3390/cimb47020126
journal_title: Current Issues in Molecular Biology
journal_nlm_ta: Curr Issues Mol Biol
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: luteolin | inflammatory bowel disease | colorectal cancer | ulcerative colitis
  | natural products
automl_pathway: 0.9523523
figid_alias: PMC11853781__F4
figtype: Figure
redirect_from: /figures/PMC11853781__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11853781__cimb-47-00126-g004.html
  '@type': Dataset
  description: 'The multi-pathway mechanisms of luteolin in inhibiting colorectal
    cancer. (The anti-cancer effects of luteolin are achieved through three major
    pathways: (1) Inhibition of cell proliferation and induction of apoptosis—downregulating
    Cyclin D1/CDK4, activating Caspase-3/9, and modulating the PI3K/Akt pathway; (2)
    suppression of cell migration and invasion—inhibiting MMPs, regulating EMT-related
    proteins (E-cadherin, N-cadherin, Vimentin), and interfering with the Wnt/β-catenin
    pathway; (3) antioxidant and anti-inflammatory effects—reducing ROS levels, enhancing
    antioxidant enzyme activities (SOD, CAT), and modulating the NF-κB signaling pathway
    to create an environment unfavorable for tumor progression)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - CCND2
  - CCND3
  - CUX1
  - SART3
  - AKT1
  - AKT2
  - AKT3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - CCL26
  - CDH1
  - FZR1
  - BCL2
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - SOD1
  - SOD2
  - SOD3
  - KEAP1
  - EGFR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - NLRP3
  - GABPA
  - NFE2L2
  - PTGS2
  - IL18
  - TNF
  - IL6
  - KRAS
  - HRAS
  - NRAS
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ddx3xb
  - tsc1b
  - tsc2
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - chmp2a
  - keap1a
  - egfra
  - kita
  - ngfra
  - nlrp3
  - nfe2l2a
  - COX2
  - tnfb
  - il6
  - rab1ab
  - Luteolin
  - ROS
  - MDA
  - GSH
  - MEK
  - Nucleus
  - Ras
  - cancer
  - colorectal cancer
---
